CDH2 and metastatic malignant neoplasm in the lymph nodes: In contrast, low levels of ARF3/N-cadherin were associated with invasion led by chain-type invasive modality, distal metastasis in xenograft models, and increased lymph-node metastasis in prostate cancer patients.